Table 4: Multivariate analysis of overall survival for C-HCC and NC-HCC patients.

Variables

Multivariate Analysis

C-HCC

NC-HCC

P value

HR

95%Cl

P value

HR

95% Cl

BMI

-

-

-

0.048

0.905

.791-0.953

Surveillance : Yes vs. No

0.64

1.265

0.907-1.764

-

-

-

Extrahepatic metastasis: Yes vs. No

0.71

1.108

0.644-1.36

-

-

-

Portal vein invasion: Yes vs. No

0.056

0.621

0.383-1.019

-

-

-

BCLC stage

 

<0.001

 

 

0.374

 

 

0

0.056

0.357

0.082-0.121

NA

NA

NA

A

0.159

0.322

0.162-0.628

0.697

1.545

0.499-4.789

B

0.952

1.026

0.439-2.410

0.510

0.833

.294-2.362

C

0.039

2.100

1.038-4.248

 

 

 

Treatment

 

<0.001

 

 

0.013

 

 

Transplant

<0.001

0.042

0.163-0.113

0.046

0.109

0.012-0.961

Resection

<0.001

0.125

0.042-0.613

0.002

0.044

0.021-0220

RFA/MWA

<0.001

0.260

0.301-0.403

0.972

0.001

0.027-1.101

Loco-regional

<0.001

0.194

0.093-0.473

0.097

0.165

0.02-1.382

Systemic

<0.001

0.249

0.131-0.901

0.079

0.213

0.038-0.642

C-HCC: Cirrhotic Hepatocellular Carcinoma group; NC-HCC: Non-Cirrhotic Hepatocellular Carcinoma group; BMI: Body mass index (cm /kg2); BCLC: Barcelona Clinic Liver Cancer; 95% Cl: Interval de Confidenta; NA: Not Applicable.